OptraHEALTH® is focused on improving outcomes for patients, providers, and payors by utilizing our next-generation Artificial Intelligence Platform – HealthFAX™.
HealthFAX™ is a Conversational AI Platform for Healthcare. HealthFAX™ uses Artificial Intelligence empowering healthcare organizations to automate pre-visit scenarios such as digital front door, intake, triage, recommendations, cost estimations, patient counseling health insurance information, etc., and post-visit scenarios such as report interrogation, follow-ups, etc.
HealthFAX™ is powered by our conversational cloud service that empowers healthcare organizations to deploy AI-powered virtual assistants for better Experience, Engagement & Education.
Chief Executive Officer
Dr Naik is the Founder CEO of OptraHEALTH. Dr Naik is geneticist with successful past exits with Roche.
Chief Executive Officer
Gauri is a biotechnologist with an extensive commercial research and entrepreneurial background. She has extensive experience working in the genetics, cytology, microbiology, molecular biology, medical imaging and bioinformatics fields.
Before founding Optra Systems Inc., she was the founder and principal scientist at BioImagene Inc., a Silicon Valley based digital pathology company which was acquired by Roche Diagnostics.
Gauri was selected as a young scientist for various research programs in biotechnology and microbiology internationally. She has 11 U.S. patents published to her credit. She has published many research papers in international journals and has participated as a speaker in many international conferences. She is on the editorial and advisory boards of many prestigious journals and forums, including the Journal of Applied & Translational Genomics and the International Organization for Rare Genetic Disorders. Gauri was also awarded with the prestigious “Woman Entrepreneur Award" by the government of India.
At Optra, Gauri is responsible for enriching the domain knowledge of her companies, as well as involved in the strategic planning and business development activities.
Abhi Gholap is the Co-founder & Chairman of OptraHEALTH. Abhi is a biomedical engineer from IIT Mumbai and Stanford GSB alumnus with 3 major exits and member of Sand Hill Angels.
Abhi is an alumnus of IIT Mumbai and Stanford University Graduate school of Business. He specializes in startups and product management. With over 4 successful startups to his credit as founder, investments in over 9 startups, 14 international patents and an active member of leading angel groups in Bay Area, Abhi handholds startups from ideas to commercialization. Abhi is TiE Silicon Valley charter member and medical advisory board member of Frost and Sullivan.
Over the years, Abhi and the companies he has founded, received a number of awards:
Abhi is also passionate about films and entertainment with National Gold Lotus award to his debut film project in India.
Dr Kotwaliwale is the Medical Director at OptraHEALTH and is physician-bioinformatician having worked in the medical genetics industry for about 20 years.
Product Manager - Knowledge Automation
Ashwin Kotwaliwale MD, PhD, has more than 15 years of experience in the biomedical informatics field. Originally trained as a medical doctor and then transitioned into bioinformatics, Dr. Kotwaliwale has great passion for developing software solutions for the healthcare and life sciences industry. He is deeply involved in technology and the domain side to accurately identify business requirements and provide innovative solutions.
Dr. Kotwaliwale’s research experience has empowered him to look at a problem from a domain focus and then provide an engineering implementation across domain boundaries. He has worked in genomics from the early days of arrays to advanced technologies such as next gen sequencing.
Recently Dr. Kotwaliwale has been involved in cutting edge software applications such as Big Data analytics from both the technology and domain application focused sides. He enjoys coding as well and has experience managing development teams and frontend customer interactions.
Director - Product Engineering
Nitin Sharma is the Director, Engineering. Nitin is a technology architect with expertise in AI/NLP and client-side implementations.
Director - Product Engineering
Nitin has more than 14 years of experience in product engineering and management. Being a technology specialist and management graduate, he has proven track record building and delivering complex systems, which leverage various expertise in space of Open Source Tech/AI/NLP. He is always passionate to take up new concepts, and building value-driven solutions around them.
Along with technical hands-on, he has good domain understanding which allows him to work comfortably and produce results from cross-functional teams.
After building solutions in microbiome, proteomics and clinical genomics, he is actively working on GeneFAX integrating voice and data science to build large scale-multi dimensional infrastructure, by driving platform features, roadmaps and capability strategy.
Dr Church is a pioneer in DNA sequencing technology and world-renowned scientist and a strong believer of new technologies for the betterment of human health.
George M. Church, PhD ’84, is professor of genetics at Harvard Medical School, a founding member of the Wyss Institute, and director of PersonalGenomes.org, the world’s only open-access information on human genomic, environmental, and trait data. Church is known for pioneering the fields of personal genomics and synthetic biology. He developed the first methods for the first genome sequence & dramatic cost reductions since then (down from $3 billion to $600), contributing to nearly all “next generation sequencing” methods and companies. His team invented CRISPR for human stem cell genome editing and other synthetic biology technologies and applications – including new ways to create organs for transplantation, gene therapies for aging reversal, and gene drives to eliminate Lyme Disease and Malaria. Church is director of IARPA & NIH BRAIN Projects and National Institutes of Health Center for Excellence in Genomic Science. He has coauthored 450 papers, 105 patents, and one book, “Regenesis”. His honors include Franklin Bower Laureate for Achievement in Science, the Time 100, and election to the National Academies of Sciences and Engineering.
Grant Wood is the chief strategist at Intermountain Healthcare for HL7 and precision genomics.
Grant Wood has been working in clinical genetics at Intermountain Healthcare for 13 years. He is responsible for creating computer systems that will support healthcare providers in delivering genetics-based clinical care, which include applications that collect family health history and genetic test result data to enable advanced clinical decision support. Grant is a member of the HL7 Clinical Genomics workgroup, and participates in activities with the Global Alliance for Genomics and Health (GA4GH), a co-chair of the IT/Bioinformatics work group for the Global Genomic Medicine Collaborative (G2MC), a co-chair of the FHIR Foundation’s DIGITizE pilot to get coded pharmacogenetic data from the lab to the EHR, and a co-chair of the WEDI Genomics workgroup. He participates with many other groups, activities, and conferences that promote family health history and clinical genomics. He also serves on the board of directors for AlphaNet, an organization that provides free disease management services to people with the genetic disorder Alpha-1 Antitrypsin Deficiency.
Geralyn Miller is the 'Director, Genomics at Microsoft', where she focuses on the intersection of genomics and AI. Ms. Miller brings extensive technical experience and has a proven track record of getting innovative technologies into mainstream adoption.
Geralyn Miller is a Director in the Artificial Intelligence and Research organization at Microsoft, where she focuses on the intersection of genomics and healthcare. Ms. Miller brings extensive business and technical experience and a proven track record of bringing innovative technologies into mainstream adoption.